414 related articles for article (PubMed ID: 27660141)
21. Diagnosis supporting algorithm for lymph node metastases from colorectal carcinoma on 18F-FDG PET/CT.
Inoue K; Sato T; Kitamura H; Ito M; Tsunoda Y; Hirayama A; Kurosawa H; Tanaka T; Fukushi M; Moriyama N; Fujii H
Ann Nucl Med; 2008 Jan; 22(1):41-8. PubMed ID: 18250986
[TBL] [Abstract][Full Text] [Related]
22. The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients.
Choi EK; Park HL; Yoo IR; Kim SJ; Kim YK
Eur Radiol; 2020 Jan; 30(1):442-451. PubMed ID: 31338654
[TBL] [Abstract][Full Text] [Related]
23. F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
Shigemoto Y; Suga K; Matsunaga N
Ann Nucl Med; 2016 May; 30(4):287-97. PubMed ID: 27007128
[TBL] [Abstract][Full Text] [Related]
24. Assessing
Sarikaya I; Sarikaya A
J Nucl Med Technol; 2019 Jun; 47(2):149-153. PubMed ID: 30413593
[No Abstract] [Full Text] [Related]
25. Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement.
Van den Bergh L; Lerut E; Haustermans K; Deroose CM; Oyen R; Isebaert S; Budiharto T; Ameye F; Mottaghy FM; Bogaerts K; Van Poppel H; Joniau S
Urol Oncol; 2015 Mar; 33(3):109.e23-31. PubMed ID: 25655681
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma.
Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF; ChangLai SP; Chieng PU
Ann Otol Rhinol Laryngol; 2000 Dec; 109(12 Pt 1):1130-4. PubMed ID: 11130825
[TBL] [Abstract][Full Text] [Related]
27. AAR-LN-DQ: Automatic anatomy recognition based disease quantification in thoracic lymph node zones via FDG PET/CT images without Nodal Delineation.
Xu G; Udupa JK; Tong Y; Odhner D; Cao H; Torigian DA
Med Phys; 2020 Aug; 47(8):3467-3484. PubMed ID: 32418221
[TBL] [Abstract][Full Text] [Related]
28. A decision tree model for predicting mediastinal lymph node metastasis in non-small cell lung cancer with F-18 FDG PET/CT.
Pak K; Kim K; Kim MH; Eom JS; Lee MK; Cho JS; Kim YS; Kim BS; Kim SJ; Kim IJ
PLoS One; 2018; 13(2):e0193403. PubMed ID: 29486012
[TBL] [Abstract][Full Text] [Related]
29. Significance of metabolic tumor volume and total lesion uptake measured using Ga-68 labelled prostate-specific membrane antigen PET/CT in primary staging of prostate cancer.
Kubilay E; Akpinar Ç; Oǧuz ES; Araz MS; Soydal Ç; Baltacı S; Ürün Y; Süer E
Urol Oncol; 2022 Sep; 40(9):408.e19-408.e25. PubMed ID: 35902300
[TBL] [Abstract][Full Text] [Related]
30. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD
BJU Int; 2017 Feb; 119(2):209-215. PubMed ID: 27207581
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
[TBL] [Abstract][Full Text] [Related]
32. Preliminary clinical assessment of dynamic
Shinya T; Otomi Y; Kubo M; Kinoshita M; Takechi K; Uyama N; Yamanaka M; Terazawa K; Toba H; Bando Y; Otsuka H; Harada M
Ann Nucl Med; 2019 Jun; 33(6):414-423. PubMed ID: 30911883
[TBL] [Abstract][Full Text] [Related]
33. 2-[
Xu L; Huang G; Wang Y; Huang G; Liu J; Chen R
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1729-1740. PubMed ID: 38150017
[TBL] [Abstract][Full Text] [Related]
34. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.
Takamochi K; Yoshida J; Murakami K; Niho S; Ishii G; Nishimura M; Nishiwaki Y; Suzuki K; Nagai K
Lung Cancer; 2005 Feb; 47(2):235-42. PubMed ID: 15639722
[TBL] [Abstract][Full Text] [Related]
35. Role of CT Density in PET/CT-Based Assessment of Lymphoma.
Flechsig P; Walker C; Kratochwil C; König L; Iagura A; Moltz J; Holland-Letz T; Kauczor HU; Haberkorn U; Giesel FL
Mol Imaging Biol; 2018 Aug; 20(4):641-649. PubMed ID: 29270848
[TBL] [Abstract][Full Text] [Related]
36. Standardized uptake value and metabolic tumor volume measured by ¹⁸F FDG PET/CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma.
Vural GU; Akkas BE; Demirel BB
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):268-73. PubMed ID: 25018135
[TBL] [Abstract][Full Text] [Related]
37. Supraclavicular lymph nodes detected by 18F-FDG PET/CT in cancer patients: assessment with 18F-FDG PET/CT and sonography.
Lee JH; Kim J; Moon HJ; Cho A; Yun M; Lee JD; Kang WJ
AJR Am J Roentgenol; 2012 Jan; 198(1):187-93. PubMed ID: 22194496
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of Metastatic Mediastinal Lymph Nodes of Non-Small Cell Lung Cancer on Preoperative F-18 FDG PET/CT.
Lee AY; Choi SJ; Jung KP; Park JS; Lee SM; Bae SK
Nucl Med Mol Imaging; 2014 Mar; 48(1):41-6. PubMed ID: 24900137
[TBL] [Abstract][Full Text] [Related]
39. The value of primary tumor (18)F-FDG uptake on preoperative PET/CT for predicting intratumoral lymphatic invasion and axillary nodal metastasis.
Jung NY; Kim SH; Kang BJ; Park SY; Chung MH
Breast Cancer; 2016 Sep; 23(5):712-7. PubMed ID: 26219608
[TBL] [Abstract][Full Text] [Related]
40. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.
Tsai CS; Chang TC; Lai CH; Tsai CC; Ng KK; Hsueh S; Yen TC; Hong JH
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1506-12. PubMed ID: 15050330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
